Affinia Therapeutics Competitors and Similar CompaniesClear all
Affinia Therapeutics's competitors and similar companies include Nouscom, Orchard Therapeutics, CAMP4 Therapeutics and Stealth BioTherapeutics.
 Nouscom Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
|  Orchard Therapeutics Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy. |  CAMP4 Therapeutics CAMP4 Therapeutics is a biotechnology company that develops antisense oligonucleotide therapeutics targeting gene expression. |  Stealth BioTherapeutics Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction. | ||
Founding Date | Founding Date 2019 | Founding Date 2015 | Founding Date 2015 | Founding Date 2016 | Founding Date 2007 |
Type | Type Private | Type Private | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Waltham, US HQ | Locations Basel, CH HQ Roma, IT | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US | Locations Cambridge, US HQ | Locations Newton, US HQ Needham, US |
Employees | Employees 613% decrease | Employees 633% increase | Employees 166 | Employees 66 | Employees 592% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $22.7m (FY, 2022) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income N/A | Net income N/A | Net income ($150.7m) (FY, 2022) | Net income ($80.4m) (FY, 2025) | Net income ($52.5m) (FY, 2021) |
Funding | |||||
Latest funding round | Latest funding round $ 60m (about 6 years ago) | Latest funding round $ 49m (over 8 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 60m | Total funding raised $ 62.6m | Total funding raised $ 310.7m | Total funding raised $ 30m | Total funding raised $ 100m |
For sources of this data, please see the company profile
View Company Profiles
Nouscom
HQ
Basel, CH
Employees
63↑ 3% increase
Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
View companyOrchard Therapeutics
HQ
London, GB
Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy.
View companyCAMP4 Therapeutics
HQ
Cambridge, US
Employees
66
CAMP4 Therapeutics is a biotechnology company that develops antisense oligonucleotide therapeutics targeting gene expression.
View companyStealth BioTherapeutics
HQ
Newton, US
Employees
59↓ 2% decrease
Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction.
View company